SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-004788
Filing Date
2022-02-11
Accepted
2022-02-11 16:15:25
Documents
13
Period of Report
2022-02-09
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K drrx-8k_20220209.htm   iXBRL 8-K 36838
  Complete submission text file 0001564590-22-004788.txt   198638

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA drrx-20220209.xsd EX-101.SCH 6411
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE drrx-20220209_def.xml EX-101.DEF 14028
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE drrx-20220209_lab.xml EX-101.LAB 23853
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE drrx-20220209_pre.xml EX-101.PRE 14737
7 EXTRACTED XBRL INSTANCE DOCUMENT drrx-8k_20220209_htm.xml XML 5386
Mailing Address 10260 BUBB ROAD CUPERTINO CA 95014
Business Address 10260 BUBB RD CUPERTINO CA 95014 4087771417
DURECT CORP (Filer) CIK: 0001082038 (see all company filings)

IRS No.: 943297098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31615 | Film No.: 22621104
SIC: 2834 Pharmaceutical Preparations